The 15 analysts offering 1 year price forecasts for EYWN have a max estimate of — and a min estimate of —.
Analyst rating
Based on 16 analysts giving stock ratings to EYWN in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter BioMerieux revenue is expected to reach 1.88 B EUR. Check out BioMerieux revenue and earnings and make informed decisions.
According to analysts, EYWN price target is 119.08 EUR with a max estimate of 130.00 EUR and a min estimate of 91.00 EUR. Check if this forecast comes true in a year, meanwhile watch BioMerieux stock price chart and keep track of the current situation with EYWN news and stock market news.
We've gathered opinions of 16 analysts rating EYWN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.